| Data |
Ora |
Fonte |
Titolo |
|---|
| 05/3/2025 | 22:30 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 05/3/2025 | 15:42 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 05/3/2025 | 13:02 | GLOBE | Ocugen Provides Business Update with Fourth Quarter and Full.. |
| 05/3/2025 | 12:59 | EDGAR2 | Form 8-K - Current report |
| 03/3/2025 | 15:00 | GLOBE | Ocugen Announces Positive Opinion of EMA’s Committee for.. |
| 03/3/2025 | 14:43 | EDGAR2 | Form 8-K - Current report |
| 27/2/2025 | 14:46 | GLOBE | Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal.. |
| 21/2/2025 | 14:00 | GLOBE | Ocugen to Host Conference Call on Wednesday, March 5, 2025.. |
| 14/2/2025 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 12/2/2025 | 14:39 | EDGAR2 | Form 8-K - Current report |
| 12/2/2025 | 13:42 | GLOBE | Ocugen, Inc. Announces Dosing Completion in the Phase 2.. |
| 07/2/2025 | 22:06 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 03/2/2025 | 12:30 | GLOBE | Ocugen Announces Positive Opinion of European Medicines.. |
| 31/1/2025 | 22:15 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
| 29/1/2025 | 15:04 | EDGAR2 | Form 8-K - Current report |
| 27/1/2025 | 12:30 | GLOBE | Ocugen, Inc. Announces Investigational New Drug Application.. |
| 16/1/2025 | 13:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1.. |
| 13/1/2025 | 12:30 | GLOBE | Ocugen, Inc. Announces Positive 2-Year Data Across Multiple.. |
| 06/1/2025 | 23:02 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 23:02 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 23:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 23:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 19/12/2024 | 12:38 | GLOBE | Data and Safety Monitoring Board Reviews Interim Safety Data.. |
| 11/12/2024 | 13:02 | GLOBE | Ocugen CEO to Present at Oppenheimer Movers in Rare Disease.. |
| 03/12/2024 | 15:50 | EDGAR2 | Form 8-K - Current report |
| 02/12/2024 | 22:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/11/2024 | 13:09 | GLOBE | Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’.. |
| 26/11/2024 | 22:50 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 20/11/2024 | 13:30 | GLOBE | Ocugen Announces European Medicines Agency Grants Orphan.. |
| 19/11/2024 | 13:02 | GLOBE | Ocugen Announces Compelling Preliminary Data for OCU410—a.. |
| 15/11/2024 | 22:17 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 15/11/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 14/11/2024 | 21:25 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 12/11/2024 | 15:55 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 19:43 | EDGAR2 | Form 8-K - Current report |
| 08/11/2024 | 12:45 | GLOBE | Ocugen Provides Business Update with Third Quarter 2024.. |
| 07/11/2024 | 12:30 | GLOBE | Ocugen Secures $30 Million in Debt Funding |
| 28/10/2024 | 11:30 | GLOBE | Ocugen Clinical Showcase Highlighting Progress in Retinal.. |
| 22/10/2024 | 13:02 | GLOBE | Data and Safety Monitoring Board Approves Initiation of.. |
| 17/10/2024 | 13:30 | GLOBE | Ocugen to Host Conference Call on Friday, November 8 at 8:30.. |
| 10/10/2024 | 13:00 | GLOBE | Ocugen to Participate in 2024 Maxim Healthcare Virtual.. |
| 09/10/2024 | 12:30 | GLOBE | Ocugen, Inc. Announces Removal of Clinical Hold on.. |
| 02/10/2024 | 12:30 | GLOBE | Ocugen to Present at the 2024 Cell & Gene Meeting on the.. |
| 26/9/2024 | 22:27 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 24/9/2024 | 13:30 | GLOBE | Ocugen to Participate in a Fireside Chat at Chardan’s 8th.. |
| 09/9/2024 | 12:30 | GLOBE | Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to.. |
| 05/9/2024 | 13:00 | GLOBE | Ocugen CSO to Participate in 5th Annual Gene Therapy for.. |
| 03/9/2024 | 13:30 | GLOBE | Ocugen to Participate in a Fireside Chat at the H.C... |
| 28/8/2024 | 12:30 | GLOBE | Ocugen Announces Completion of Dosing in Subjects with.. |
Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
